Test Price
2,800 AED✅ Home Collection Available
ZFHX4 Gene (Congenital Ptosis) Genetic Test in UAE | 2,800 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
- 🔬 Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Lab
- 🚚 Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM‑11 PM)
- 🩺 Clinical Guidance: Telephonic Post-Test Clinical Interpretation by DHA-Licensed Genetic Counsellor
- 📋 Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
The ZFHX4 Gene Congenital Ptosis Test uses next‑generation sequencing (NGS) to identify pathogenic variants in the ZFHX4 gene associated with isolated or syndromic congenital ptosis, enabling accurate molecular diagnosis and family‑centred genetic counselling. This UAE‑based, DHA‑regulated service combines hospital‑grade home collection with expert clinical interpretation, delivering results in 3‑4 weeks.
| Feature | Our ZFHX4 NGS Test | Closest Alternative (Sanger Panel) |
|---|---|---|
| Methodology | Full‑gene NGS (all exons, splice sites) | Targeted Sanger sequencing of common variants |
| Variant Detection | SNVs, indels, copy‑number variants | Only pre‑defined point mutations |
| Analytical Sensitivity | 99.9% | ~95% for targeted variants |
| Turnaround Time | 3 – 4 weeks | 2 – 3 weeks |
| Price (AED) | 2,800 | ~1,800 |
Physician Insight & Safety Protocols
“This advanced genetic test offers a precise molecular diagnosis for congenital ptosis, but its interpretation must be woven into a thorough clinical evaluation by a paediatric neurologist or clinical geneticist. Our team, under DHA licence 9294403, walks alongside your family with pre‑test counselling, empathetic support, and personalised post‑test guidance.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403)Advisory: Medication and Clinical Precautions
Do not discontinue any prescribed medication without explicit instruction from your treating physician. Always inform your genetic counsellor about all medications and supplements you are taking. This test does not replace ongoing clinical monitoring or emergency care.
Exclusion Criteria and Emergency Red Flags
- Exclusion Criteria: Testing is not performed on individuals without a pre‑test genetic counselling session or those unable to provide informed consent. Neonates must be accompanied by a legal guardian.
- Red Flag Symptoms: If ptosis appears suddenly with double vision, slurred speech, facial droop, or limb weakness, this may indicate a stroke. Call 998 or proceed to the nearest Emergency Department immediately.
- Any unexpected severe headache or eye pain during sample collection – stop the procedure and seek urgent care.
Patient FAQ & Clinical Guidance
1. What is the ZFHX4 gene and why is this test needed?
The ZFHX4 gene encodes a transcription factor critical for eyelid muscle development. Mutations in this gene are a known cause of isolated or syndromic congenital ptosis. This test confirms the diagnosis, enabling accurate genetic counselling and recurrence risk assessment for families.
2. How accurate is this NGS test and can it be done from home?
Our next‑generation sequencing achieves >99.9% analytical sensitivity and specificity. We offer VIP mobile phlebotomy at your home across all Emirates under strict cold‑chain protocols. A certified phlebotomist arrives with hospital‑grade equipment, ensuring sample integrity from vein to lab.
3. How long do results take and will a doctor explain them?
Results are delivered in 3–4 weeks, accompanied by a telephonic consultation with a DHA‑licensed genetic counsellor who interprets clinical implications. This personalised session translates complex genomic data into actionable medical advice and psychological support.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with the following UAE federal regulations:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring secure handling of genetic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing health information systems and digital records.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – governing clinical testing safety and patient consent.
Your genetic data is encrypted, access‑controlled, and used solely for diagnostic purposes with your explicit informed consent.
Clinical & Logistical Metadata
| Test Name | ZFHX4 Gene (Congenital Ptosis) Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3 – 4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next‑Generation Sequencing (NGS) – full‑gene analysis covering all exons and splice sites |
| ICD-10-CM Code | Q10.0 (Congenital ptosis) |
| LOINC Code | 55233-1 (Genetic testing by next generation sequencing) |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians